| Serial Number | 97021112 |
| Word Mark | IGNAFIQUE |
| Filing Date | Friday, September 10, 2021 |
| Status | 605 - ABANDONED - EXPRESS AFTER PUB |
| Status Date | Friday, August 16, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 19, 2022 |
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Friday, August 16, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285 |
| Event Date | Event Description |
| Tuesday, September 14, 2021 | NEW APPLICATION ENTERED |
| Tuesday, October 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 15, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 16, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 7, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, July 19, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 29, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 19, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 13, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, February 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Friday, March 3, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, February 15, 2023 | SOU EXTENSION 1 FILED |
| Saturday, March 4, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, March 7, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, March 20, 2023 | EARLY EXTENSION OF USE REFUSED |
| Tuesday, August 15, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 15, 2023 | SOU EXTENSION 2 FILED |
| Thursday, August 17, 2023 | SOU EXTENSION 2 GRANTED |
| Friday, August 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, February 19, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, February 20, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 15, 2024 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Friday, August 16, 2024 | ABANDONMENT - AFTER PUBLICATION |
| Friday, August 16, 2024 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |
| Monday, February 19, 2024 | SOU EXTENSION 3 FILED |
| Monday, February 19, 2024 | SOU EXTENSION 3 GRANTED |